Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: Relationship with neuro-degeneration

Biogerontology

Volumn 12, Issue 5, 2011, Pages 451-454

  Corsi, Massimiliano M ^a,b   Licastro, Federico ^c   Porcellini, Elisa ^c   Dogliotti, Giada ^a   Galliera, Emanuela ^a   Lamont, John L ^d   Innocenzi, Paul J ^d   Fitzgerald, Stephen P ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Randox Laboratories Ltd   (United Kingdom)

Author keywords

Alzheimer's disease diagnosis and prognosis; Fast cognitive decline; L selectin; P selectin; Slow cognitive decline

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; VASCULOTROPIN;

AGED; ALZHEIMER DISEASE; ASTROCYTOSIS; CHRONIC INFLAMMATION; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MICROGLIA; NERVE DEGENERATION; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALZHEIMER DISEASE; BRAIN; CHEMOKINE CCL2; COGNITION DISORDERS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-8; L-SELECTIN; MALE; P-SELECTIN; PILOT PROJECTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 83255186699     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-011-9335-6     Document Type: Conference Paper

References (20)

1. Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L (2010) Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease. J Alzheimers Dis 21(2):557-567
2. American Psychiatric Association (1997) Diagnostic and statistical manual of mental disorders: DSM-III-R, vol 58, 3rd edn. American Psychiatric Association, Washington
3. Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, Rozzini L, Di Luca M, Lenzi GL, Romanelli G, Caimi L, Padovani A (2002) Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci 203-204:189-193 (Pubitemid 35287398)
4. Chiappelli M, Borroni B, Archetti S, Calabrese E, Corsi MM, Franceschi M, Padovani A, Licastro F (2006a) VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res 9:485-493 (Pubitemid 46100670)
5. Chiappelli M, Tumini E, Porcellini E, Licastro F (2006b) Impaired regulation of immune response in cognitive decline and Alzheimer's disease: lessons from genetic association studies. Expert Rev Neurother 6:1327-1336 (Pubitemid 44580955)
6. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321-339 (Pubitemid 27465015)
7. Doody RS, Massman P, Dunn JK (2001) A method for estimating progression rates in Alzheimer disease. Arch Neurol 58(3):449-454 (Pubitemid 32217462)
8. Eikelenboom P, Zhan SS, Kamphorst W, van der Valk P, Rozemuller JM (1994) Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch 424(4): 421-427 (Pubitemid 24185396)
9. Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485-495 (Pubitemid 41139258)
10. Ewers M, Mielke MM, Hampel H (2010) Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol 45(1):75-79
11. Gamble JR, Skinner MP, Berndt MC, Vadas MA (1990) Prevention of activated neutrophil adhesion endothelium by soluble adhesion protein GMP140. Science 249:414-417
12. Hochstrasser T, Weiss E, Marksteiner J, Humpel C (2010) Soluble cell adhesion molecules in monocytes of Alzheimer's disease and mild cognitive impairment. Exp Gerontol 45(1):70-74
13. Khalil Z, LoGiudice D, Khodr B, Maruff P, Masters C (2007) Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. J Alzheimers Dis 11(1): 25-32 (Pubitemid 46376705)
14. Licastro F, Chiappelli M, Ruscica M, Carnelli V, Corsi MM (2005) Altered cytokine and acute phase response protein levels in the blood of children with Downs syndrome: relationship with dementia of Alzheimer's type. Int J Immunopathol Pharmacol 18:165-172 (Pubitemid 40343469)
15. Licastro F, Chiappelli M, Caldarera CM, Porcellini E, Carbone I, Caruso C, Lio D, Corder EH (2011) Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer's disease as shown by partially overlapping of gene variant profiles. J Alzheimer Dis 23:421-431
16. Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ (2010) The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res 183(1):44-51
17. Nielsen HM, Londos E, Minthon L, Janciauskiene SM (2007) Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol Dis 26(1):27-35 (Pubitemid 46436485)
18. Rentzos M, Michalopoulou M, Nikolaou C, Cambouri C, Rombos A, Dimitrakopoulos A, Vassilopoulos D (2005) The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J Neurol Sci 228(2):129-135 (Pubitemid 40202957)
19. Rosendorff C, Beeri MS, Silverman JM (2007) Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol 16(3):143-149
20. Stefani A, Sancesario G, Pierantozzi M, Leone G, Galati S, Hainsworth AH, Diomedi M (2009) CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia. J Neurol Sci 283(1-2):109-115